IBRX: ImmunityBio, Inc. Stock

by  •  • Comments Off on IBRX: ImmunityBio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,116.54
Enterprise Value ($M) 2,721.61
Book Value ($M) -488.13
Book Value / Share -0.57
Price / Book -4.34
NCAV ($M) -686.48
NCAV / Share -0.80
Price / NCAV -3.08

Profitability (mra)
Return on Invested Capital (ROIC) -1.37
Return on Assets (ROA) -1.03
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.21
Current Ratio 3.36

Balance Sheet (mrq) ($M)
Current Assets 184.59
Assets 382.93
Liabilities 871.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.74
Operating Income -344.18
Net Income -413.56
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -391.24
Cash from Investing -12.25
Cash from Financing 281.63

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,307,871 4,314,168 30.32
2025-04-16 3,128,094 7,816,018 40.02
2025-04-15 3,016,844 8,238,384 36.62
2025-04-14 2,795,082 10,313,255 27.10

(click for more detail)

Similar Companies
HLVX – HilleVax, Inc. HOWL – Werewolf Therapeutics, Inc.
HUMA – Humacyte, Inc. IDXX – IDEXX Laboratories, Inc.
IDYA – IDEAYA Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io